399 related articles for article (PubMed ID: 8634067)
1. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
3. [Prospects for antisense therapy].
Maekawa T
Rinsho Ketsueki; 1995 May; 36(5):410-8. PubMed ID: 7783344
[TBL] [Abstract][Full Text] [Related]
4. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
5. Antisense approaches to cancer gene therapy.
Mercola D; Cohen JS
Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide therapeutics: clothing the emperor.
Gewirtz AM
Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
[TBL] [Abstract][Full Text] [Related]
7. Antisense therapy.
Narayanan R; Akhtar S
Curr Opin Oncol; 1996 Nov; 8(6):509-15. PubMed ID: 8971471
[TBL] [Abstract][Full Text] [Related]
8. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
Oberbauer R
Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide-based therapeutics for cancer.
Dean NM; Bennett CF
Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
[TBL] [Abstract][Full Text] [Related]
10. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
11. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.
Tidd DM
Anticancer Res; 1990; 10(5A):1169-82. PubMed ID: 2241097
[TBL] [Abstract][Full Text] [Related]
12. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligodeoxynucleotides.
Stein CA; Narayanan R
Curr Opin Oncol; 1994 Nov; 6(6):587-94. PubMed ID: 7827170
[TBL] [Abstract][Full Text] [Related]
14. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
Kausch I; Böhle A
Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotide therapy in urology.
Kausch I; Böhle A
J Urol; 2002 Jul; 168(1):239-47. PubMed ID: 12050550
[TBL] [Abstract][Full Text] [Related]
16. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
17. Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides.
Toulmé JJ; Bourget C; Compagno D; Yurchenko L
Parasitology; 1997; 114 Suppl():S45-59. PubMed ID: 9309768
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical pharmacology of antisense oligonucleotides.
Marcusson EG; Yacyshyn BR; Shanahan WR; Dean NM
Mol Biotechnol; 1999 Aug; 12(1):1-11. PubMed ID: 10554769
[TBL] [Abstract][Full Text] [Related]
19. Antisense therapy for cancer.
Gleave ME; Monia BP
Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]